2Doval HC.ClassⅢantiarrhythmic agents in cardic failure:lessons from clinical trial with a focus on the grupo de estudio de sobrevida en la in-suficiencia cardiaca en agrentina(GESICA)[].The American Journal of Cardiology.2004
3Exner DV,Reiffel JA,Epstein AE,et al.Beta-Blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia:AVID trial[].Journal of the American College of Cardiology.2001